N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes. The test will be available to the public in Japan in January 2020.
What is N-NOSE?
Merit of taking a cancer screening test
Why nematodes?
The world's first biological diagnostic technology. At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.
Message from CEO
Company Profile
List of Officers
On Feb 15, our N-NOSE was introduced on NHK WORLD-JAPAN'S "BIZ STREAM."
For more details → 2020.02.17
On Feb 15, a charity concert event to empower children who suffer from cancer "LIVE EMPOWER CHILDREN 2020 Suppo . . .
Paper on N-NOSE clinical study jointly conducted between Nampuh Hospital and Hirotsu Bio Science was in a journ . . .
Paper on N-NOSE clinical study jointly conducted between Nampuh Hospital and Hirotsu Bio Science was in a journa . . .
N-NOSE was introduced on Nippon TV''s "news every." on Feb 4. For more details, visit the program website . . .
N-NOSE was introduced on RKB's "Kyo-kan News" today. For more details, visit the program website → 2020.02.07
CEO Hirotsu was on Fuji TV's "Tokudane!" and our nematode cancer test N-NOSE was introduced. For more details, . . .
N-NOSE was introduced on NHK's "Ohayo Nippon." For more details, visit the program website → 2020.01.29
On Jan 28 (Tue), CEO Hirotsu gave a lecture at 94th Hiroshima University Seminar (for the staff and students of . . .
On Feb 2 (Sun), CEO Hirotsu gives a lecture at 4th Osaka Association of Medical Technologsts. For more details, . . .
The world’s first cancer screening using biological diagnostic technology